Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |